NEW YORK, NY / ACCESSWIRE / July 27, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Endo International Plc (NASDAQ:ENDP)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/endo-international-plc-loss-submission-form?prid=8209&wire=1
Lead Plaintiff Deadline: August 18, 2020
Class Period: August 8, 2017 - June 10, 2020

Allegations against ENDP include that: (i) Endo's and/or its subsidiaries' contributions to the opioid crisis (including, but not limited to, their opioid products' disproportionately negative impact on New York and the fraud that Defendants perpetrated on the New York insurance market) were larger in scope than the Company had represented; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Kirkland Lake Gold Ltd. (NYSE:KL)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/kirkland-lake-gold-ltd-loss-submission-form?prid=8209&wire=1
Lead Plaintiff Deadline: August 28, 2020
Class Period: January 8, 2018 - November 25, 2019

Allegations against KL include that: (i) Kirkland lacked adequate internal controls over financial reporting, especially as it relates to its projections of risks, reserve grade, and all-in sustaining costs; (ii) as a result of the known, but undisclosed, impending acquisition of Detour, the Company's projections relating to its risks, reserve grade, and all-in sustaining costs were false and misleading; (iii) the Company's financial statements and projections were not fairly presented in conformity with International Financial Reporting Standards; (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company's business, operations, and prospects and/or lacked a reasonable basis and omitted material facts.

J2 Global, Inc. (NASDAQ:JCOM)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/j2-global-inc-loss-submission-form?prid=8209&wire=1
Lead Plaintiff Deadline: September 8, 2020
Class Period: October 5, 2015 - June 29, 2020

Allegations against JCOM include that: (1) J2 Global engaged in undisclosed related party transactions; (2) J2 Global used misleading accounting to hide requisite impairments and underperformance in acquisitions; (3) several so-called independent members of the Company' board of directors and audit committee were not disinterested; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong